|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$71,758.44 |
3.85% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$60,813.30 |
3.26% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$54,898.06 |
2.94% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$51,385.05 |
2.75% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$49,581.84 |
2.66% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$49,194.24 |
2.64% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$44,467.50 |
2.38% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,416.49 |
2.38% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$44,451.21 |
2.38% |
| Waters Corporation |
WAT |
941848103 |
148 |
$44,250.52 |
2.37% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$40,973.40 |
2.20% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$40,786.68 |
2.19% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$40,420.96 |
2.17% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$40,305.94 |
2.16% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$39,143.30 |
2.10% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$38,844.88 |
2.08% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$38,019.23 |
2.04% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$37,301.95 |
2.00% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$37,338.88 |
2.00% |
| Steris Plc |
STE |
G8473T100 |
169 |
$37,185.07 |
1.99% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$37,208.06 |
1.99% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$36,993.27 |
1.98% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$36,588.03 |
1.96% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$36,014.88 |
1.93% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$36,035.90 |
1.93% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$36,053.64 |
1.93% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$36,028.56 |
1.93% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$35,441.66 |
1.90% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$35,206.94 |
1.89% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$35,150.87 |
1.88% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$34,689.16 |
1.86% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$33,688.55 |
1.81% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$33,220.53 |
1.78% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$32,983.82 |
1.77% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$32,994.17 |
1.77% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$32,499.60 |
1.74% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$31,743.46 |
1.70% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$31,570.74 |
1.69% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$31,337.22 |
1.68% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$30,829.35 |
1.65% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$30,541.92 |
1.64% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$29,915.60 |
1.60% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$29,344.55 |
1.57% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$29,042.64 |
1.56% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$28,841.70 |
1.55% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$27,661.80 |
1.48% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$27,488.95 |
1.47% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$24,646.96 |
1.32% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$22,411.18 |
1.20% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$21,598.00 |
1.16% |
| US Dollar |
$USD |
|
1,918 |
$1,918.01 |
0.10% |
| Australian Dollar |
$AUD |
|
441 |
$309.99 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|